Results 141 to 150 of about 2,968 (201)

Phase III Trial: Single Low-Dose 5 mg Dexamethasone with NEPA for Preventing 168 h Nausea and Vomiting of Diverse Highly or Moderately Emetogenic Chemotherapy (LD-NEPA). [PDF]

Diseases
He Y, Huang X, Rong K, Hong Y, Lou F, Zheng B, Tan W, Chen Q, Shi H, Xiao L.   +9 more
europepmc   +1 more source

5-HT₃ receptor antagonists for preventing postoperative nausea and vomiting after gynecological surgery: A systematic review and network meta-analysis. [PDF]

Int J Gynaecol Obstet
Xu H, Rong L, Yang S, Xing J, Dong H, Liu H, Chen X, Liu L.   +7 more
europepmc   +1 more source

The Implementation Imperative in Clinical Pharmacology. [PDF]

Clin Pharmacol Ther
Rowland Yeo K.
europepmc   +1 more source

Effects of the 5-Hydroxytryptamine 3 Receptor Antagonist Palonosetron on Hemostasis: An In Vitro Study Using Thromboelastography. [PDF]

Medicina (Kaunas)
Shin HJ, Koo BW, Kim JN, Park JI, Na HS.
europepmc   +1 more source

The safety and efficacy of NEPA in preventing postoperative nausea and vomiting after general anesthesia during gastrointestinal cancer surgery: a single-center retrospective study. [PDF]

Transl Cancer Res
Zhang Y, Li C, Xu L, Zhang J, Wu D, Bai Y, Li H.   +6 more
europepmc   +1 more source

Aprepitant use during chemotherapy and association with survival in women with early breast cancer. [PDF]

J Natl Cancer Inst
Botteri E, Hjorth S, Conforti F, Bagnardi V, Andreassen BK, Støer NC, Bhargava S, Ursin G, Gandini S, Sloan EK, Chang A.   +10 more
europepmc   +1 more source

Omission of dexamethasone in prophylaxis for highly emetogenic chemotherapy in patients with breast cancer. [PDF]

Einstein (Sao Paulo)
Rebouças CV, Alves RB, Yamada AMTD, Del Giglio A, Cruz FJSM.   +4 more
europepmc   +1 more source

Netupitant versus aprepitant: model-predicted neurokinin-1 receptor occupancy and implications for long-delayed nausea and vomiting prevention. [PDF]

Support Care Cancer
Iihara H, Bianchini G, Aapro M, Licata L, Bernareggi A, Navari RM, Park YH, Jordan K, Vidal M, Scotté F, Roeland EJ, Schwartzberg L, Rugo HS.   +12 more
europepmc   +1 more source

Correction to: Comparative effectiveness of netupitant-palonosetron plus dexamethasone versus aprepitant-based regimens in mitigating chemotherapy-induced nausea and vomiting: a meta-analysis of randomized controlled trials. [PDF]

Oncologist
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Palonosetron

Drugs, 2012
Lily P H Yang
exaly   +2 more sources